There is considerable HIV-1 variation in patients. The extent of the variation is due to the high rate of viral replication, the high viral load, and to the errors made during viral replication.
INTRODUCTION
Human immunodeficiency virus type 1 (HIV-1) is genetically diverse both within and between infected individuals [225, 226, 228] . The high rate of viral replication, the size of the viral population in individual patients [234, 235] , and extensive recombination [150, 151] all contribute to genetic variation [242, 241] . However, the root cause of HIV-1 diversification is mutations that arise during retroviral replication. The ability to rapidly diversify allows HIV-1 to evade the host's immune system [231] , alter its tropism, and develop resistance to antiretroviral drugs [232] . Hence, the fidelity of replication contributes to the adaptability and fitness of the virus.
Mutations can occur at three stages of retroviral replication: (i) when viral RNA is transcribed from the provirus by the host DNA-dependent RNA polymerase II (pol II), (ii) when the single-stranded viral RNA genome is converted into double-stranded DNA by the viral reverse transcriptase (RT), or (iii) when the provirus is copied by the host DNA-dependent DNA polymerase when the infected cell replicates. Although the available in vitro data are incomplete, several groups have suggested that RT is the major cause of mutations made during HIV-1 replication [157, 61, 73, 74] . RT lacks exonucleolytic proofreading activity, and in vitro studies have suggested that it is error-prone (discussed below) [75, 157, 88, 99] . The cellular DNA replication machinery has a much higher fidelity with a mutation rate between 1x10 -9 to 1x10 -12 mutations/bp/cycle, which implies that the host DNA polymerases make a negligible contribution to the errors that arise during active HIV-1 replication. [236, 237] . Although the contribution of the errors made by host RNA pol II to the fidelity of HIV-1 replication is not known, it could be significant [239, 61] . Experiments with a reporter gene inserted into a retroviral LTR have shown that approximately two-thirds of mutations occur either during RNA transcription or first (minus)-strand viral DNA synthesis [74, 61] . However, these data do not differentiate between the errors made by RNA pol II and RT. Host factors can also contribute to the overall error rate of HIV-1. In the absence of HIV-1 vif, APOBEC3G can cause extensive Gto-A mutations by deaminating cytidines in the minus-strand of the viral DNA [246] . It is also possible that host DNA repair enzymes cause mutations in the newly synthesized viral DNA [254, 122] .
A number of groups have measured the fidelity of HIV-1 RT in vitro by copying a DNA or RNA template encoding a target in which mutations can easily be identified, most commonly the -complementing peptide of Escherichia coli (E. coli) -galactosidase (lacZ). These assays have identified RT residues involved in nucleotide discrimination, binding, and incorporation [40, 75, 89, 208, 130] . In vitro, HIV-1 RT has a high rate of nucleotide misincorporation, in the range of 5.9x10 -4 to 5.3x10 -5 mutations/bp/cycle (reviewed in [108, 65] ). Despite the fact that most groups have used a similar mutagenic target (lacZ), the various groups have reported different error rates and, despite the fact that several groups used similar templates, there is little agreement on the specific errors RT makes [75, 80, 99, 40, 208] . A part of the problem is that HIV-1 RT fidelity in vitro depends both on the exact nature of the recombinant RT used in the assay, 3 and on the particular assay conditions [89, 189] . It has also been reported that recombinant HIV-1 RT is more error-prone than the RTs of other retroviruses [156, 208, 243, 244, 245] . Together, these data have led to proposals that the low fidelity of RT makes HIV-1 replication particularly error-prone [207, 157] .
In vivo (cell culture) systems that include a number of the viral and host components that contribute to the fidelity of HIV-1 replication have also been developed. Using an HIV-1 vector containing a lacZ reporter gene, Mansky and Temin reported a mutation rate of 3.4x10 mutations/bp/cycle [73, 102] , some 10-20-fold lower than the rates reported for purified HIV-1 RT in vitro [88, 89, 40, 208] , but within 3-fold of the retroviral average of 1.5x10 -5 mutations/bp/cycle [240, 63, 56, 73, 100] . To date, most of the measurements of HIV-1 fidelity have been based on the frequency of phenotypic inactivation of LacZ [70, 71, 72, 68] . Thus, little is known about the specificity of the errors made in vivo [73] .
We used a vector-based system to determine the nature, position, and frequency of mutations generated in a single-cycle of HIV-1 replication in cultured cells. Our HIV-1 vector carries lacZ, and was designed so that circular forms of the HIV-1 DNA can replicate in E. coli as plamids. More than 4x10 4 independent replicated copies of the genome of an HIV-1 vector can be recovered from a single plate of infected HOS cells, a nearly 20-fold improvement [73, 56, 63, 100, 102] . Individual colonies were screened for the presence of functional LacZ, and mutant HIV-lacZ DNAs were sequenced. We characterized the mutations that arose in both the forward and reverse orientations of the lacZ reporter gene. The orientation of lacZ affected the types and positions of mutations, but not the rate, suggesting that the nature of the mutations depends on the strand present in viral RNA.
MATERIALS AND METHODS

Plasmid construction
4 Two different vector-based systems were used to generate virus stocks for the analysis of HIV-1 fidelity. A NotI-MluI shuttle cassette, derived from pHIV-SH [111] , was modified for use in both vector systems. To eliminate redundancy and to shorten the cassette, both the Pol II promoter and lacO sequences were removed by PCR-mutagenesis, and a 477 bp sequence containing lacZ derived from Litmus-29 was inserted in place of the lacO (New England Biolabs, Ipswich, MA). The final cassette contained a zeocin resistance gene with an upstream EM-7 promoter (EM-Zeo R ), a lacZ sequence (lacZ), and a ColE1 origin of replication (oriE).
Two versions of the shuttle cassette were created with the lacZ sequence in opposite orientations: the forward (lacZ-F, LZF) and reverse (lacZ-R, LZR) orientations ( Figure 1A ).
The 2-vector system ( Figure 1B ) included pCMV-VSV-G, and either pNLZeoIN-R-E-.LZF or pNLZeoIN-R-E-.LZR. The pCMV-VSV-G vector (obtained from Dr. Jane Burns at the University of California, San Diego, CA) was used to express vesicular stomatitis virus G envelope glycoprotein. The vector used to produce viral RNA, pNLZeoIN-R-E-.LZF or pNLZeoIN-R-E-.LZR, contained the full-length NL4-3 isolate of HIV-1 [247] along with a stop codon in vpr (R-) and a deletion in the env gene (Env) and was derived from pHIV1-SH [111] by replacement of the NotI-MluI shuttle cassette in the nef reading frame. A D116N active site mutation in integrase (IN-) was introduced into pNLZeoIN-R-E-using the QuikChange II XL site-directed mutagenesis kit (Stratagene, La Jolla, CA) to facilitate recovery of unintegrated circular viral DNAs.
The 4-vector system included pCMV-VSV-G, pRSV-REV, pMDL-SH.IN-, and either pSICO-LZF or pSICO-LZR. The pRSV-REV vector contained the joined second and third exons of HIV-1 rev under the transcriptional control of an RSV U3 promoter. The pMDL-SH.INvector, which encodes HIV-1 Gag and Pol and contains an RRE, was derived from pMDLg/pRRE by replacing the gag-pol genes with the equivalent sequences from NL4-3, followed by the introduction of a D116N integrase inactivating mutation (IN-) as described above. Both the pRSV-REV and pMDLg/pRRE lentiviral vectors were obtained from Addgene Inc. (Cambridge, MA), where they were deposited by Dr. Didier Trono (EPFL SV-DO, Lausanne, Switzerland). The vector used to produce viral RNA, pSICO-LZF or pSICO-LZR, was derived from pSICO-XBX [210] by introduction of our shuttle cassette as a NotI-MluI 5 fragment, and contained a chimeric 5'LTR with a CMV promoter in place of U3, and a HIV Psi packaging/RRE RNA export signal Cells, transfection, and infection HEK (human embryonic kidney) 293T and HOS (human osteosarcoma) cells were maintained in Dulbecco's modified Eagle medium (Invitrogen, Carlsbad, CA) supplemented with 5 % (vol/vol) fetal bovine serum, 5 % (vol/vol) newborn calf serum, 100 g/mL pencillin G, and 100 g/mL streptomycin (Quality Biological, Gaithersburg, MD). Recombinant virus stocks were generated by calcium phosphate-mediated co-transfection of 293T cells seeded at 9x10 5 cells in 100 mm culture plates using either the 2-vector or 4-vector-based system: (i) 2-vector system-derived viral particles were produced by co-transfection with 15 g pNLZeoIN-R-E.LZF (or pNLZeoIN-R-E.LZR) and 4 g pCMV-VSV-G, (ii) 4-vector system-derived viral particles were produced by co-transfection with 10 g pMDL-SH IN-, 5 g pRSV-REV, 15 g pSICO-LZF (or pSICO-LZR) and 4 g pCMV-VSV-G per plate. Virus-containing culture supernatants were harvested 48 h post-transfection, clarified by filtration through a 50 mL Steriflip 0.22 m pore-size filter units (Millipore, Billerica, MA) , and stored at -80 o C until use.
The amount of recombinant virus was determined using HIV-1 p24 antigen enzyme-linked immunosorbant assay kits, obtained from PerkinElmer (Boston, MA). On the day of infection, virus stocks were thawed and treated with 100 U DNase I (Invitrogen, Carlsbad, CA) plus 5 mM MgCl 2 for 1 h at 37 o C to remove any vector DNA carried over from the transfection.
Recombinant virus equivalent to 500 ng of p24 was then added to 150 mm culture plates along with 8 g/mL polybrene (Sigma-Aldrich, St. Louis, MO), followed by the addition of 2x10 6 cells/plate HOS cells per plate.
Recovery of unintegrated HIV-lacZ DNAs
Circularized unintegrated HIV-lacZ DNAs were recovered from infected HOS cells 48 h post-infection using a modified Hirt extraction procedure. The presence of intact and mutant lacZ in the recovered viral DNA was determined by cloning the DNA directly into an E. coli strain that contained the -complementing segment of -galactosidase. In brief, the viral DNAs were resuspended in 6 L of ddH 2 O and 1 L was electroporated into 45 L of ElectroMax E. coli DH10B bacterial cells (Invitrogen, Carlsbad, CA) using a BTX Electro Cell Manipulator 600 (Biotechnologies and Experimental Research, Inc., San Diego, CA). Recipient E. coli cells were subjected to a single 7.5 ms pulse (field strength 1.5 kV/cm, capacitance 25 F, resistance 186 ) using a 1 mm gap E-Shot Standard electroporation cuvette (Invitrogen, Carlsbad, CA) at room temperature. To prevent clonal expansion, transformed E. coli were allowed to recover for only 10 min prior to plating onto 15 cm-diameter low-salt Luria-Bertani plates containing 100 mM IPTG, 50 g/mL zeocin, and 250 g/mL X-Gal (InVivoGen, San Diego, CA). The colonies were allowed to grow for 24 h at 37 o C and the -galactosidase activity was monitored by the color of the colonies: white-to-light blue (inactive/reduced activity) or blue (fully active) were scored using an ECount electronic colony counter (Heathrow Scientific LLC, Vernon Hills, IL). Individual mutant colonies were inoculated into 96-well blocks containing 1.5 mL low-salt Luria-Bertani media containing 50 g/mL zeocin, and cultured for 48-72 h at 37 o C. Plasmid DNA was extracted using a Biorobot 3000 (Qiagen, Valencia, CA) and the lacZ-coding region was sequenced (Macrogen USA Inc., Rockville, MD). Restriction enzyme digestion of plasmids recovered from 192 clones showed 7 that less than 1 % were derived from vector DNA carried over from transfected 293T cells.
Transformation of vector plasmid pSICO-LZF into DH10B yielded only a small fraction of white-to-light blue colonies (14 out of 206,400), suggesting that the transformation and growth of the E. coli cells made an insignificant contribution to the mutations obtained in lacZ .
Classification of mutations and compilation of lacZ mutation spectra
Sequenced viral DNA products encoding the entire full-length LacZ-fusion protein (477 nt) were compiled by alignment and separated from aberrant deleted products using Sequencher (4) indel (insertions/deletions) mutations, including deletions, deletions with insertions, duplications, and multiples of single nucleotide substitutions plus frameshifts (cutoff of 3 or more consecutive bases). Mutation spectra were compiled from the sequences in each mutation class to summarize the total number, types, and positions of errors detected within the 174 nt lacZ target sequence.
Frameshifts and transition/transversion substitutions were tabulated for each type of mutation.
To validate the nature of Class 3 multiple nucleotide substitutions, 414 nearly complete HIV-1 subtype B genomes (1 per patient) were retrieved from the Los Alamos HIV database (http://www.hiv.lanl.gov/) and compiled by alignment. Using B.FR.1983.HXB2-LAI-IIIB-BRU as a reference, a Perl script was written to assess the fraction of multiple A-to-G substitutions compared to multiple C-to-T substitutions within each sequence.
Determination of mutation frequencies and rates
In the vectors we used, LacZ was expressed as part of a fusion protein derived from a 477 nt region of Ipswich, MA) . This 477 nt region was comprised of a regulatory region (108 nt: CAP site, promoter, lac operator and a ribosome binding site), the first 5 codons of lacZ (15 nt), a multiple cloning site/polylinker region (180 nt), and 58 codons of lacZ (174 nt). Although the actual ATG start site was upstream of the polylinker, the total length of the mutational lacZ target sequence was defined as the 174 nt including the first glycine GGA codon after the polylinker to the first TAA termination codon.
This 174 nt region is consistent with the lacZ targets previously used to measure HIV-1 RT fidelity [75, 73, 40] . Because the polylinker region of the LacZ-fusion protein makes no functional contribution to LacZ activity, mutations detected in this region (typically termination codons and indels) were excluded from analysis of the overall mutation rate. Mutation frequency was determined by dividing the number of mutational events by the total number of colonies screened. Mutation rate was determined by dividing mutation frequency by the length of the lacZ target (174 nt). Because some of the mutations will be silent, this strategy necessarily underestimates the actual mutation rate. A small number of mutations were detected which did not alter the protein sequence (typically 3 rd base codon positions); these were invariably found with another mutation that did alter the protein sequence.
Comparative analysis of lacZ-F and lacZ-R mutation spectra Data were analyzed by log linear categorial analysis, contingency table analysis and related methods. The number of mutations in the 174 nt sequence of lacZ were detailed in 2 x 174 tables for each pairwise comparison of lacZ mutational profiles. A Likelihood Ratio ChiSquare (LR Chi-Sqaure) test was first performed to determine the homogeneity of counts across each pair of profiles compared. This was a conservative test to determine whether statistically significant but spurious event(s) were present. Positions where there were frequent mutations (hotspots) were first identified by a "search and discovery" strategy, and contingency tables were subsequently decomposed into orthogonal components to permit a series of additive LR ChiSquare tests. Prospective hotspots were then subjected to a global Fisher's exact test to determine statistical significance, whereby compounding type I error rate was controlled through use of a Bonferroni correction. To that end, the criterion probability value adopted for significance in these tests was based on the typical level of significance ( = 0.05) divided by the number of tests (75-174 sites) in order to maintain a family-wise error rate. Maintaining a minimal criterion of at least 0.01, statistical significance of hotspot differences between lacZ-F and lacZ-R mutation spectra were reported at the 0.01, 0.001 and 0.0001 levels.
RNA secondary structure predictions
RNA secondary structure predictions were made using mfold v3.2 software 
RESULTS
Vector-based measurement of HIV-1 replication fidelity
To accurately assess the nature and position of errors made during viral replication, we compared two vector expression systems designed to facilitate the recovery of large numbers of LacZ phenotypic inactivation was similar for both vector systems, only a fraction of the mutant lacZ DNAs could be used to determine the mutation rate in the forward or reverse lacZ orientation (Table 1 and Text S1). Based on the number of useful mutant lacZ DNAs, the frequency of LacZ mutation was similar for the 4-vector (0.22-0.25 %) and 2-vector (0.18-0.22 %) systems (P = 0.4751; 
Effect of lacZ orientation on the types of in vivo mutations
Although the integrated HIV-1 genome is double-stranded DNA, only one strand is copied into viral RNA by the host DNA-dependent RNA pol II. This also means that RT uses different templates to synthesize the two strands of the viral DNA, the minus-strand from RNA and the plus-strand from DNA. Our assay does not discriminate between errors made by RNA pol II and RT. By recovering mutations on a multicopy plasmid, we were more likely to score mutations generated during minus-strand DNA synthesis than during plus-strand DNA synthesis (for an explanation, see Text S2). Experiments with an SNV vector showed that approximately two-thirds of the observed mutations were generated either by pol II or during minus-strand DNA synthesis [61, 62] .
We compared all of the mutations that arose in the forward and reverse orientations of lacZ. To simplify the comparison, the data presented in the main text were all derived from the 4-vector system. Similar results were obtained using the 2-vector system (see Tables S1-S2 and Figures S1-S4). As described in Materials and Methods, lacZ DNA mutations were divided into classes according to the types of mutations detected. Single nucleotide (nt) substitution errors (Class 1) were the most frequent (75-83 % of the total) ( Table 2) . Single nucleotide frameshifts (Class 2) accounted for 5-6 % of mutants. We found multiple nucleotide substitutions (Class 3) in another 9-16 % of mutant lacZ sequences, which, if they were counted independently, would have represented 34-46 % of the total detected mutations. The final type of mutations (Class 4) detected were indel mutations (insertions, deletions, and deletions with insertions) comprising 3-4 % of the lacZ mutants.
We first compared the frequencies of the specific types of errors generated in the forward and reverse lacZ orientations (Table 3A- 
(4) Insertions, deletions, and deletions with insertions (indels)
Finally, we recovered a small number of lacZ DNAs containing insertions or deletions (small or large), or deletions with insertions (11 lacZ-F and 13 lacZ-R). All of the indel mutations altered the reading frame of lacZ ( Figure 5 ). Because these mutations did not localize to any specific nucleotide positions, the entire 174 nt length of lacZ was considered scorable for Class 4 mutants ( Table 4 ).
The frequency of indels was strikingly similar in the two lacZ orientations (P = 1;
Fisher's exact test), with deletions substantially outnumbering insertions (LZF: 10 of 11; LZR: 8 of 13). The deletions ranged from 4-44 nt. The insertion or deletion junction in both large and small indels typically involved a short direct repeat of 1-3 nt, and/or a preceding run of identical nucleotides in the direction of minus-strand synthesis. A minor fraction of indels involved a deletion of 2-3 nt followed by an insertion of a similar or length (LZF: 0 of 11; LZR: 2 of 13).
Finally, two lacZ-R DNAs were found to contain a single nucleotide substitution and frameshift separated by 3-9 nucleotides.
The orientation of lacZ does not affect the in vivo mutation frequency
Three separate approaches were used to determine the overall in vivo mutation rate for a single round of HIV-1 replication (Table 2 ). Since our measurements include only mutations that inactivate lacZ, these determinations underestimate the actual mutation rate (see Discussion).
We classified individual errors as either related (dependent) or separate (independent) mutations.
Single nucleotide changes (Class 1 and 2), and indels (Class 4) were considered single mutational events. However, the multiple substitutions in Class 3 were treated as either dependent or independent events, because it was unclear whether they were caused by a host enzyme that modifies the nucleic acid or an error-prone polymerase (see Discussion). If the Class 3 mutations were excluded, the overall mutation rate in the forward lacZ orientation was mutations/bp/cycle (P < 0.0001; Fisher's exact test). Class 3 mutations (as dependent or independent events) appeared to modestly increase the overall mutation rate, and a similar increase was seen in both the forward and reverse lacZ orientation. If the multiple A-to-G substitutions of Class 3 were introduced by a host enzyme (ADAR), then their relative contribution to the overall forward lacZ mutation rate would be 2.1x10 mutations/bp/cycle (lacZ-R); P = 0.061. These results suggest that while the specific mutations are affected by which strand of lacZ is expressed in viral RNA, the overall mutation rate of is not.
DISCUSSION
Nature and position of mutational hotspots in vivo
Most analyses of mutations generated in vitro by RT have used a mutational target similar to lacZ-F. There have been relatively few cell-free in vitro studies using an RNA template with the lacZ-F orientation [80, 99] , and no studies using either an RNA or a DNA template equivalent to the lacZ-R orientation. Although similar lacZ DNA sequences have been used as targets in multiple in vitro studies, the patterns of reported mutations are vastly different. Furthermore, the overall mutation rate reported for RT in vitro is significantly higher than the overall mutation rate in vivo. Because the published in vivo data do not provide detailed information about the spectrum of mutations, it has not been possible to consider the mechanisms by which the mutations arose [73, 102] . Our findings extend the available in vivo observations and provide information about the nature, position, and frequency of the mutations.
The classes and proportions of mutations we obtained using HIV-1 lacZ were consistent with previous reports for HIV-1 [73, 102] , SNV [56, 63, 121] , and BLV [100] . Base substitutions are the most common mutations, with transitions predominating over transversions. Although the proportion of single nucleotide frameshifts and indels have been reported to make up 10-25 % of the total, we observed much lower fractions of 5-6 % and 3-4 %, respectively. We also found more multiple mutations (including both G-to-A and A-to-G) than previously reported.
The mutational hotspots seen in vivo depended upon the strand of lacZ that was expressed in the viral RNA. Although the nature and relative frequencies of the various classes of mutations were similar in both lacZ orientations, the sequence and/or structural context of the template influenced the location of hotspots. Both single (Class 1) and multiple (Class 3) nucleotide substitutions are orientation dependent. Although the Class 1 (single) G-to-A and C-to-T substitutions were randomly distributed, Class 3 A-to-G and G-to-A substitutions usually occurred next to specific neighboring nucleotides. In contrast, frameshift (Class 2) and indel (Class 4) mutations were much less frequent, and most were in the same nucleotide runs in both lacZ orientation. This result differs from in vitro findings where single nucleotide frameshift deletions were much more frequent [204, 75, 90, 205, 80] , and frameshift insertions did not necessarily match adjacent template nucleotides [40, 101] . The pattern of mutational hotspots seen in vivo in lacZ-F or lacZ-R did not match any of the published in vitro hotspot data obtained using purified RT to copy lacZ [40, 101, 75, 89, 80, 99] .
Possible underlying mechanism(s) of in vivo mutations
The in vivo-based system detects the mutations made by both RT and RNA pol II but 
Determination of an in vivo mutation rate for HIV-1 using lacZ
Although it is widely believed that HIV-1 replication is exceptionally error prone, we show here that the in vivo forward mutation rate of HIV-1, measured by the inactivation of lacZ, is approximately 1.4x10
-5 mutations per bp per cycle. This rate is approximately 20-fold lower than the in vitro error rate for RT using a DNA template [88, 99, 40, 101, 163, 208] and 17-fold lower than the rate measured using an RNA template [163, 99] . Our reported mutation rate for HIV-1 in HOS cells is also about 3-fold lower than earlier reported rates in HeLa and CEM 21 cells [73, 102] , and is similar to the average rate reported for other retroviruses (1.5x10
The primary advantage of using the lacZ-based system to study HIV-1 replication fidelity is that the nature of the mutations that arise in vivo can be determined. An accurate mutation rate depends on (i) the number of mutable positions in lacZ, (ii) whether mutations in both DNA strands are scored, and (iii) whether mutants with multiple changes in the DNA (Class 3 and 4) are counted as single or multiple mutation(s). One limitation of using lacZ to determine the in vivo mutation rate of HIV-1 is that silent mutations are not detected. Based on a the collection of mutations generated by recombinant RT in vitro, it has been proposed that mutations can be detected in approximately 40 % of the nucleotides in the promoter and coding region of lacZ. The specific number of mutable target sites in a 280 nt lacZ have been reported as 113 for substitutions, 150 for frameshifts, and 280 for indels [75, 203, 80, 156, 56] .
These numbers could not be used to analyze the data from our in vivo assay because only 174 nt of lacZ were the same in our experiments and the published data. However, we have confirmed that single nucleotide missense mutations could be detected at a minimum of 71 out of 174 nt positions (Table 4 ). This suggests that our measured mutation rate may be 2-3 fold lower than the actual overall mutation rate. The mutation rate of HIV-1 was previously determined using different constraints to be 3.4x10
mutations/bp/cycle [73] . When the rate was recalculated using the 174 nt target, the mutation rate was 2.4x10
mutations/bp/cycle, which is similar to our result (for details, see Text S3 and Table S3 ). Based on the published in vivo data and our data, HIV-1 replication is not error prone relative to other retroviruses. This implies that, at least in the context of the replicating virus, HIV-1 RT is not significantly more error prone than other retrovirusal RTs. Effect of the vector on LacZ phenotypic inactivation frequencies a Recovery: The number of mutant colonies (white or light blue) was divided by the total number of colonies recovered x 100 = frequency of LacZ phenotypic inactivation. b Analysis:
(1) The number of recovered lacZ DNAs that aligned with the reference sequence (477 nt) was divided by number of mutant colonies. (2) The number of lacZ DNAs with mutation(s) in the lacZ target sequence (174 nt.) was divided by the number of recovered lacZ DNAs that aligned with the reference sequence (477 nt). c Final interpretation: The number of lacZ DNAs with scorable mutation(s) in the lacZ target sequence (174 nt) was divided by the corrected total number of recovered colonies x 100 = actual frequency of lacZ mutants. The orientation of lacZ does not affect the HIV-1 mutation rate (4-vector system) a Mutation frequency: The number of mutants (mutations) 
SUPPORTING INFORMATION
Text S1: SUPPORTING RESULTS
Recovery and analysis of phenotypic mutant HIV-lacZ DNAs
Although the fraction of the viral DNAs in which lacZ was inactivated was similar for the two vector systems, only about one quarter of the inactivated lacZ DNAs that were sequenced could be used to determine the mutation rate. Approximately 50 % of the inactive mutants had sustained a particular large deletion that removed most of the lacZ gene. We suspect that this deletion was the result of a recombination/gene conversion event in E. coli. Because the lacZ gene was lost at a much higher rate when the newly replicated viral DNA was used to transform E. coli than when supercoiled plasmid DNA was used to transform E. coli, it is possible that some of the newly replicated viral DNA had nicks or gaps in one or both strands which increased the frequency of the events leading to the deletion. As described in Materials and Methods, 
Text S2: SUPPORTING RESULTS
Effect of lacZ orientation on the types of mutations in vivo
By recovering mutations on a multicopy plasmid, we are more likely to score mutations generated during RNA synthesis and minus-strand DNA synthesis than during plus-strand DNA synthesis. If host-mediated DNA repair occurs without strand specificity, the number of mutations generated during plus-strand DNA synthesis would be reduced by, at most, a factor of two. However, without DNA repair, a mutation in the plus-strand would be scored as wild-type because the E. coli cells would contain a mixture of wild-type (from the minus-strand) and mutant (from the plus-strand) plasmids, and the cells would express functional LacZ. Thus, a comparison of the mutations obtained with the two orientations of lacZ in the viral RNA should make it possible to generate and compare, two related, but distinct data sets. The obvious differences seen in the mutations obtained with the two orientations of lacZ support this interpretation. 
Text S3: SUPPORTING RESULTS
Re-calculation of the previous reported HIV-1 mutation rate in the lacZ-F orientation
In previous calculations of mutation rates, a lacZ target gene of 280 nucleotides was proposed to have 113 nt where substitutions give rise to an inactive phenotype. In the previous calculations it was assumed that there were 150 nt at which frameshifts would cause an inactive phenotype and 280 nt for indels: [75, 203, 80, 156, 56] . Given the differences between the lacZ we used and the published versions, we re-analyzed a subset of previously reported in vivo data to determine a comparable overall mutation rate using same sequence we used for our vectors [73] . As originally reported in Mansky, L.M. and Temin, H.M. 1995. J. Virol. 69(8) :5087-5094, a sum total of 64 mutations were detected in both the forward and reverse lacZ orientations.
Based on the constraints given for the 280 nt lacZ target, the in vivo mutation rate was reported to be 3.4x10
-5 mutations/bp/cycle. To facilitate a comparison with our data, we re-evaluated the data of Mansky and Temin using only the mutations in the same 174 nt region of lacZ-F we used in our calculations (Table S3) . Using this method, the overall total HIV-1 mutation rate, based on the Mansky and Temin data, was 2.4x10
-5 mutations/bp/cycle. 
